Desi Peneva, MS

213-740-0575
email
Google Scholar

Desi Peneva is the research program lead at the USC Schaeffer Center where she manages all phases of research project execution from study design and implementation to results delivery and dissemination as a member of the Value of Life Sciences Innovation team. She has held various research, academic, and professional consulting positions, most recently as an associate director and research scientist leading a team of researchers executing health policy and pharmaceutical economics studies at a consultancy to the life sciences industry. Desi has expertise in evidence synthesis, evidence generation, advisory panel engagement, and scientific communication in various therapeutic areas including Alzheimer's disease, oncology, diabetes, HIV/AIDS, multiple sclerosis, rheumatoid arthritis, cardiovascular and respiratory diseases, and maternal and infant disorders. Her research has examined the social value of new and existing health technologies and the impact of health policy on health and economic outcomes. She received her master's degree in economics from Illinois State University and her bachelor's degree in finance from Minnesota State University Moorhead.

Recent Work

Can a Free Virtual Outreach Series Increase Alzheimer’s Disease Awareness?

Lack of awareness remains one of the biggest barriers to participation in Alzheimer’s disease clinical trials, especially among underrepresented groups. New ways to connect with communities and to expand access to clinical trials include a virtual Alzheimer’s disease informational series, which reveals important insights about how people engage with virtual content differently than at in-person events.

By Alison Sexton Ward, PhD, Nancy Lynn, MA and Desi Peneva, MS
Categorized in
- Articles
- Evidence Base
Recommendations To Address Key Recruitment Challenges of Alzheimer’s Disease Clinical Trials

An advisory panel of experts convened in 2020 to assess the critical challenges facing recruitment in Alzheimer’s clinical trials and develop a set of recommendations to overcome them.
Categorized in
Health Technology Assessment in the U.S. – A Vision for the Future

Health technology assessment (HTA) can help achieve the dual health policy goals of ensuring affordability and encouraging innovation.
Categorized in
- Research
- White Paper
The Value of Treatment for COVID-19

The COVID-19 pandemic has imposed significant and far-reaching health and economic costs. This white paper models and monetizes the health-related benefits of two hypothetical treatments administered either before or after hospitalization; both generate substantial value.
Categorized in
- Research
- White Paper
Health Technology Assessment for the U.S. Healthcare System

A white paper from the USC Schaeffer Center-Aspen Institute Advisory Panel on health technology assessment in the U.S. Experts explore how to better link the price of health technologies to the benefits they provide to patients while ensuring a sustainable healthcare ecosystem that supports innovation.
Categorized in
- Research
- White Paper

Desi Peneva, MS's contact information

Desi Peneva, MS's Bio

Recent Work

Can a Free Virtual Outreach Series Increase Alzheimer’s Disease Awareness?

Recommendations To Address Key Recruitment Challenges of Alzheimer’s Disease Clinical Trials

Health Technology Assessment in the U.S. – A Vision for the Future

The Value of Treatment for COVID-19

Health Technology Assessment for the U.S. Healthcare System